CYTOTHERAPY

Scope & Guideline

Transforming Cancer Research through Cell-Based Therapies.

Introduction

Delve into the academic richness of CYTOTHERAPY with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1465-3249
PublisherELSEVIER SCI LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1999 to 2024
AbbreviationCYTOTHERAPY / Cytotherapy
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

The journal "Cytotherapy" focuses on the field of cell therapy, emphasizing the transformative potential of cellular therapies and regenerative medicine. It encompasses a broad range of topics related to the biology, engineering, and clinical application of cells, particularly stem cells and immune cells, in therapeutic contexts.
  1. Cell Therapy Mechanisms and Applications:
    Research explores the biological mechanisms by which various cell types, especially stem cells and immune cells, exert therapeutic effects in different clinical conditions, such as cancer, autoimmune diseases, and degenerative disorders.
  2. Manufacturing and Quality Control:
    The journal emphasizes the development of robust manufacturing processes for cell-based therapies, including adherence to Good Manufacturing Practices (GMP), quality control measures, and the implementation of automated systems to enhance scalability and reproducibility.
  3. Clinical Trials and Translational Research:
    Cytotherapy features studies that bridge the gap between laboratory research and clinical application, reporting on the safety, efficacy, and long-term outcomes of cell therapies in diverse patient populations.
  4. Innovative Technologies and Methodologies:
    The journal highlights advancements in technologies for cell engineering, including CRISPR/Cas9 gene editing, microfluidics, and novel bioreactor designs, which contribute to improved therapeutic products.
  5. Extracellular Vesicles and Secretome Research:
    There is a significant focus on the role of extracellular vesicles derived from stem cells in mediating therapeutic effects, including their immunomodulatory properties and potential in regenerative medicine.
  6. Regulatory and Ethical Considerations:
    Research addresses the regulatory frameworks and ethical considerations surrounding the development and use of cell therapies, ensuring compliance and patient safety.
Cytotherapy is at the forefront of several trending and emerging themes in regenerative medicine and cell therapy. These trends highlight the evolving landscape of research and clinical applications in the field.
  1. Engineered Cell Therapies:
    There is a significant increase in research focused on engineered cell therapies, particularly the development of CAR-T and other genetically modified immune cells, reflecting the growing interest in precision medicine and targeted therapies.
  2. Extracellular Vesicles as Therapeutics:
    Research exploring the therapeutic potential of extracellular vesicles derived from stem cells has surged, emphasizing their role in mediating immunomodulatory effects and tissue regeneration.
  3. Automation and Robotics in Manufacturing:
    The incorporation of automation and robotics into cell therapy manufacturing processes is a rapidly emerging trend, aimed at enhancing efficiency, consistency, and scalability in production.
  4. Personalized Medicine Approaches:
    Emerging themes around personalized medicine, including the use of patient-derived cells for tailored therapies, are gaining traction, as they promise improved outcomes and reduced adverse effects.
  5. Regulatory Science and Guidelines:
    There is a growing focus on regulatory science, addressing the complexities of bringing cell therapies to market and ensuring compliance with evolving regulatory frameworks.
  6. Microfluidics and Novel Bioreactor Systems:
    Research into microfluidic technologies and advanced bioreactor systems is trending, driven by the need for scalable and efficient production methods for cell therapies.

Declining or Waning

While the journal has seen growth in several areas, some themes are gradually declining in prominence. This may reflect shifts in research focus, advancements in technology, or changing clinical priorities.
  1. Traditional Stem Cell Therapies:
    There has been a noticeable decline in publications focused solely on traditional stem cell therapies without innovative modifications or applications, as the field shifts towards more advanced and engineered solutions.
  2. Basic Biological Studies:
    Research that primarily delves into the fundamental biology of stem cells without direct therapeutic implications appears to be waning, as there is a greater emphasis on translational research and clinical applications.
  3. Single-Cell Analysis Techniques:
    Although single-cell technologies were once a hot topic, the frequency of papers solely dedicated to basic single-cell analysis techniques has decreased, possibly due to the rapid evolution of more integrated and application-focused methodologies.
  4. Animal Models of Disease:
    The journal has seen less emphasis on animal model studies that do not directly translate to human applications, as researchers increasingly prioritize studies that have immediate clinical relevance.

Similar Journals

Regenerative Engineering and Translational Medicine

Innovating Biomaterials for Tomorrow's Therapies
Publisher: SPRINGER HEIDELBERGISSN: 2364-4133Frequency: 4 issues/year

Regenerative Engineering and Translational Medicine is an esteemed academic journal published by Springer Heidelberg, focusing on the interdisciplinary fields of biomaterials, biomedical engineering, and cell biology. With an ISSN of 2364-4133 and an E-ISSN of 2364-4141, the journal has carved a niche for itself since its inception in 2015, showcasing cutting-edge research that bridges the gap between scientific findings and practical applications in regenerative medicine. As a recognized platform in its field, it is currently positioned within Q3 quartiles in biomaterials, biomedical engineering, and medicine (miscellaneous), with a Scopus ranking that reflects its growing influence among peers. The journal aims to disseminate high-quality, peer-reviewed articles that highlight advancements in regenerative engineering, further advancing both theoretical and applied research. Scholars and practitioners seeking to stay at the forefront of the ever-evolving landscape of regenerative health solutions will find invaluable insights and innovations within these pages. Join a community of leading thinkers and explore the journal's comprehensive research contributions, which are crucial for fostering partnerships between academia and industry in the quest for transformative medical solutions.

Cell Stem Cell

Elevating Research Standards in Stem Cell and Molecular Biology
Publisher: CELL PRESSISSN: 1934-5909Frequency: 12 issues/year

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

Exploring the Depths of In Vitro Development
Publisher: SPRINGERISSN: 1071-2690Frequency: 10 issues/year

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, published by SPRINGER, is a pivotal journal in the fields of cell biology and developmental biology, focusing on in vitro studies that enhance our understanding of animal cellular mechanisms and development. With an ISSN of 1071-2690 and an E-ISSN of 1543-706X, this esteemed journal offers a platform for researchers to present their findings and contribute to the body of knowledge necessary for advancements in biological sciences. As a recognized publication, it holds a 2023 category quartile of Q4 in Cell Biology and Developmental Biology, and Q3 in miscellaneous Medicine, reflecting its competitive position yet inviting critical submissions that can span multidisciplinary approaches. Though currently not open access, it serves as an essential resource for professionals, researchers, and students dedicated to unraveling the complexities of cellular processes in an ever-evolving field. The journal has been continuously published since 1986, signifying its long-standing commitment to fostering scientific discourse and innovation.

Stem Cells Translational Medicine

Unlocking the Potential of Stem Cell Technology
Publisher: OXFORD UNIV PRESSISSN: 2157-6564Frequency: 12 issues/year

Stem Cells Translational Medicine, published by Oxford University Press, is a leading open-access journal that has been at the forefront of stem cell research since its launch in 2012. With an impressive impact across various categories, it occupies Q2 in Cell Biology and is highly recognized in Q1 for both Developmental Biology and Miscellaneous Medicine in 2023. Its strong Scopus rankings highlight its significance in the fields of Biochemistry, Genetics, and Molecular Biology, achieving an outstanding percentile ranking of 93rd in Developmental Biology. The journal provides a pivotal platform for researchers, professionals, and students to publish and access cutting-edge findings that contribute to the understanding and application of stem cell technology. With a commitment to disseminating high-quality scientific knowledge, Stem Cells Translational Medicine plays a vital role in advancing research and innovation within the rapidly evolving landscape of regenerative medicine.

BIOCELL

Unveiling the Secrets of Cellular Innovation
Publisher: TECH SCIENCE PRESSISSN: 0327-9545Frequency: 12 issues/year

BIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.

Current Stem Cell Reports

Bridging Gaps in Stem Cell Knowledge
Publisher: SPRINGER HEIDELBERGISSN: Frequency: 4 issues/year

Current Stem Cell Reports, published by Springer Heidelberg, is an esteemed academic journal that has emerged as a pivotal resource in the fields of Cell Biology, Developmental Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has consistently contributed to the evolving discourse on stem cell research and its applications, providing a platform for innovative studies and reviews through 2024. With a notable impact indicated by its quartile rankings—Q2 in Developmental Biology and Genetics, and Q3 in Cell Biology and Molecular Biology—it engages a diverse audience of researchers, professionals, and students who seek high-quality, accessible research insights. Although offering a traditional access model, the content remains vital for those invested in understanding the implications of stem cell advancements. Located in Switzerland and operating from the heart of Heidelberg, this journal aspires to bridge gaps in knowledge and stimulate collaboration in the burgeoning field of stem cell science.

CELL RESEARCH

Connecting Research to Real-World Impact
Publisher: SPRINGERNATUREISSN: 1001-0602Frequency: 12 issues/year

CELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.

Stem Cells International

Advancing the Frontiers of Stem Cell Research
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.

Stem Cell Reviews and Reports

Unlocking Innovations in Cell Biology and Cancer
Publisher: SPRINGERISSN: 2629-3269Frequency: 8 issues/year

Stem Cell Reviews and Reports is a prestigious journal published by SPRINGER specializing in the dynamic field of stem cell research, encompassing various aspects of cell biology and cancer research. With an ISSN of 2629-3269 and E-ISSN of 2629-3277, this journal serves as an essential resource for academics, offering insightful reviews and cutting-edge reports from 2009 to 2024. The journal has achieved a commendable Q2 ranking in both Cancer Research and Cell Biology categories as of 2023, highlighting its significant contribution to the scientific community. Additionally, with Scopus rankings placing it in the 74th percentile for both biochemistry and cell biology, it is recognized for its high-quality articles that foster innovative approaches in stem cell therapy and regenerative medicine. As an Open Access publication, Stem Cell Reviews and Reports ensures that its comprehensive content is readily available to researchers, professionals, and students, promoting collaboration and advancement in this vital area of study.

EXPERIMENTAL CELL RESEARCH

Exploring the Frontiers of Cell Biology
Publisher: ELSEVIER INCISSN: 0014-4827Frequency: 20 issues/year

EXPERIMENTAL CELL RESEARCH is a highly respected journal published by Elsevier Inc, specializing in the dynamic and ever-evolving field of Cell Biology. With an impact factor positioned in the Q2 quartile for 2023, it ranks at the 124th position out of 285 in the Scopus Ranks, indicating a solid reputation among peers in the domains of biochemistry, genetics, and molecular biology. Since its inception in 1950, the journal has contributed significantly to the dissemination of groundbreaking research, providing a platform for studies that explore the nuances of cellular mechanisms, processes, and experimental methodologies. Although the journal currently does not offer open access, its commitment to high-quality, peer-reviewed research continues to attract submissions from leading scientists and scholars across the globe. Researchers, professionals, and students alike will find this journal an invaluable resource for keeping abreast of current developments and innovative breakthroughs in cellular science.